BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2232229)

  • 1. [Basic concept and clinical application of monoclonal antibody].
    Nihon Rinsho; 1990 Aug; 48 Suppl():938-1124. PubMed ID: 2232229
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationale for clinical use of immunotoxins in cancer and autoimmune disease.
    Byers VS; Baldwin RW
    Semin Cell Biol; 1991 Feb; 2(1):59-70. PubMed ID: 1954344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical application of monoclonal antibodies].
    Yata J
    Ryumachi; 1984 Aug; 24(4):288-94. PubMed ID: 6393366
    [No Abstract]   [Full Text] [Related]  

  • 4. [Some diagnostic and therapeutic applications of the monoclonal antibodies].
    Melino G; Plebani A; Riches P
    Clin Ter; 1984 Jun; 109(5):455-65. PubMed ID: 6236937
    [No Abstract]   [Full Text] [Related]  

  • 5. Specific targeting of cancer with monoclonal antibodies: diagnostic and therapeutic applications.
    Abrams PG; Morgan AC; Fritzberg R
    Cancer Invest; 1990; 8(2):287-8. PubMed ID: 2400950
    [No Abstract]   [Full Text] [Related]  

  • 6. Perspectives in the prevention and treatment of acute graft versus host disease.
    Herve P
    Bone Marrow Transplant; 1991; 7 Suppl 2():117-9. PubMed ID: 1715225
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic use of immunotoxins.
    Cobb PW; LeMaistre CF
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):6-13. PubMed ID: 1509295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies in immunodiagnosis and immunotherapy of human cancer.
    Colnaghi MI; Canevari S; Ménard S
    Eur J Surg Oncol; 1988 Feb; 14(1):1-7. PubMed ID: 3278936
    [No Abstract]   [Full Text] [Related]  

  • 9. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-2 receptor-directed therapies: antibody- or cytokine-based targeting molecules.
    Strom TB; Kelley VR; Murphy JR; Nichols J; Woodworth TG
    Adv Nephrol Necker Hosp; 1994; 23():347-56. PubMed ID: 8154364
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeted kill: from umbrellas to monoclonal antibodies.
    Byers VS; Baldwin RW
    J Clin Immunol; 1992 Nov; 12(6):391-405. PubMed ID: 1287032
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal antibodies in the diagnosis and treatment of childhood diseases.
    Matthay KK
    Adv Pediatr; 1985; 32():101-37. PubMed ID: 3909771
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoclonal antibodies: does sufficient selectivity to cancer cells exist for therapeutic application?
    Oldham RK
    J Biol Response Mod; 1987 Jun; 6(3):227-34. PubMed ID: 3298552
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical applications of monoclonal antibodies.
    Krakauer H
    Eur J Clin Microbiol; 1985 Feb; 4(1):1-9. PubMed ID: 3886376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of steroid-resistant graft-versus-host disease after allogeneic bone marrow transplantation with anti-CD3/TCR monoclonal antibodies.
    Hebart H; Ehninger G; Schmidt H; Berner B; Reuss-Borst M; Waller HD; Müller CA; Einsele H
    Bone Marrow Transplant; 1995 Jun; 15(6):891-4. PubMed ID: 7581087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune status in two brothers with Omenn's syndrome: no discernible chimerism on FACS analysis using a monoclonal antibody specific for a maternally restricted HLA antigen.
    Tachinami T; Koizumi S; Yachie A; Yamagami M; Yokoi T; Ohno I; Taniguchi N; Takada I; Kawashima A; Okada Y
    Am J Pediatr Hematol Oncol; 1990; 12(3):343-50. PubMed ID: 2240484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical applications of monoclonal antibodies].
    Boucheix C
    Rev Med Interne; 1985 Oct; 6(4):403-10. PubMed ID: 3906817
    [No Abstract]   [Full Text] [Related]  

  • 18. [Monoclonal antibodies in research and clinical medicine].
    Voigt A
    Kinderarztl Prax; 1989 Oct; 57(10):479-87. PubMed ID: 2689756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of anti-CD5 ricin A chain immunoconjugate for prevention of acute graft-vs.-host disease after HLA-identical marrow transplantation.
    Przepiorka D; LeMaistre CF; Huh YO; Luna M; Saria EA; Brown CT; Champlin RE
    Ther Immunol; 1994 Apr; 1(2):77-82. PubMed ID: 7584486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.